---
category: corporate-action
circular_id: 327da5be23520936
date: '2025-11-18'
description: NCLT approved scheme of amalgamation for merger of MEDINOVA DIAGNOSTIC
  SERVICES LTD into VIJAYA DIAGNOSTIC CENTRE LTD with record date November 25, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={2D2A2709-C86C-435F-9ADF-EE2A9C9EDBDE}&noticeno=20251118-49&dt=11/18/2025&icount=49&totcount=58&flag=0
impact: high
impact_ranking: high
importance_ranking: high
justification: Complete merger impacting shareholders with trading halt and mandatory
  share conversion ratio of 22:1
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251118-49&attachedId=
processing:
  attempts: 1
  content_hash: f7bf4ba43aadfee8
  processed_at: '2025-11-18T15:33:04.512722'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-11-18T13:46:11+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={2D2A2709-C86C-435F-9ADF-EE2A9C9EDBDE}&noticeno=20251118-49&dt=11/18/2025&icount=49&totcount=58&flag=0
severity: high
source: bse
stocks:
- MEDINOVA
- VIJAYAPATH
tags:
- amalgamation
- merger
- nclt-order
- trading-suspension
- share-swap
- medinova-diagnostic
- vijaya-diagnostic
title: Amalgamation of MEDINOVA DIAGNOSTIC SERVICES LTD into VIJAYA DIAGNOSTIC CENTRE
  LTD
---

## Summary

BSE has announced that trading in equity shares of MEDINOVA DIAGNOSTIC SERVICES LTD (Scrip Code: 526301) will be suspended from November 25, 2025, following NCLT Hyderabad Bench approval of its amalgamation into VIJAYA DIAGNOSTIC CENTRE LTD. Shareholders of MEDINOVA will receive 1 equity share of VIJAYA DIAGNOSTIC for every 22 equity shares held as per the approved scheme.

## Key Points

- NCLT Hyderabad Bench has approved the Scheme of Amalgamation
- MEDINOVA DIAGNOSTIC SERVICES LTD (Transferor Company) to merge into VIJAYA DIAGNOSTIC CENTRE LTD (Transferee Company)
- Share swap ratio: 22 equity shares of MEDINOVA (Face Value Rs. 10) = 1 equity share of VIJAYA DIAGNOSTIC (Face Value Re. 1)
- Trading in MEDINOVA shares prohibited from November 25, 2025
- Circular reference: DR-763/2025-2026

## Regulatory Changes

No new regulatory changes introduced. This circular implements a corporate action pursuant to NCLT-approved amalgamation scheme under applicable company law provisions.

## Compliance Requirements

- **Trading Members**: Must not deal in equity shares of MEDINOVA DIAGNOSTIC SERVICES LTD from November 25, 2025 onwards
- **VIJAYA DIAGNOSTIC CENTRE LTD**: Required to issue and allot equity shares to eligible MEDINOVA shareholders based on the approved swap ratio
- **Shareholders**: Entitlement to receive VIJAYA DIAGNOSTIC shares determined as per holdings on record date

## Important Dates

- **November 18, 2025**: Circular issuance date
- **November 25, 2025**: Record date for determining shareholder entitlement; Trading suspension effective date

## Impact Assessment

**Shareholder Impact**: MEDINOVA shareholders will experience significant dilution with a 22:1 consolidation ratio. Fractional shares treatment not specified in the circular.

**Trading Impact**: Complete cessation of trading in MEDINOVA shares from record date, requiring investors to exit positions before November 25, 2025.

**Market Impact**: Medium - affects specific scrip and its shareholders; VIJAYA DIAGNOSTIC may see increased shareholding base post-merger completion.

**Operational Impact**: Transfer and vesting of all assets, liabilities, and undertakings of MEDINOVA into VIJAYA DIAGNOSTIC as per NCLT-approved scheme.